HRTSETF / FundTema Heart & Health ETF
Verdicts genuinely change. Free email alert the moment HRTS's does — no target price to set, unlike a price alert.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Tema Heart & Health ETF ETF · Tema ETF Trust
46 holdings · as of 2026-08-31 (2.5 months ago)
NON-COMPLIANT 12.77% of portfolio weight is in non-compliant holdings, over the 5% threshold.
46 holdings, 37 matched (90% of weight). Portfolio as of 2026-08-31, filed 2026-10-30. Source: SEC Form N-PORT.
1.89% of this portfolio’s income is non-permissible — weighted across holdings, computed over 80% of portfolio weight (32 of 46 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
76.8% compliant 0.0% questionable 12.8% non-compliant 10.4% unscreened
All holdings (46)
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| LLY Eli Lilly & Co | COMPLIANT | 11.11% | AAOIFI5.2% Usmani38.6% Dow Jones Islamic6.4% S&P Shariah6.9% MSCI Islamic38.6% MSCI Islamic M-Series6.9% FTSE Shariah38.6% |
| TMO Thermo Fisher Scientific Inc | COMPLIANT | 5.12% | AAOIFI20.5% Usmani40.3% Dow Jones Islamic23.4% S&P Shariah22.9% MSCI Islamic40.3% MSCI Islamic M-Series22.9% FTSE Shariah40.3% |
| UNH UnitedHealth Group Inc | NON_COMPLIANT | 5.04% | AAOIFI20.4% Usmani23.7% Dow Jones Islamic20.4% S&P Shariah18.8% MSCI Islamic23.7% MSCI Islamic M-Series18.8% FTSE Shariah23.7% |
| NOVO-B.CO Novo Nordisk A/S | COMPLIANT | 4.79% | AAOIFIpass Usmanipass Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| MRK Merck & Co Inc | COMPLIANT | 4.31% | AAOIFI14.7% Usmani41.5% Dow Jones Islamic21.8% S&P Shariah20.9% MSCI Islamic41.5% MSCI Islamic M-Series20.9% FTSE Shariah41.5% |
| JNJ Johnson & Johnson | COMPLIANT | 3.90% | AAOIFI7.6% Usmani24.4% Dow Jones Islamic10.9% S&P Shariah11.7% MSCI Islamic24.4% MSCI Islamic M-Series11.7% FTSE Shariah24.4% |
| RO.SW Roche Holding AG | COMPLIANT | 3.76% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicpass MSCI Islamic M-Seriespass FTSE Shariahpass |
| Revolution Medicines Inc | UNSCREENED | 3.68% | no in-house ratios for this holding |
| CYTK Cytokinetics Inc | NON_COMPLIANT | 3.53% | AAOIFI3.9% Usmani20.7% Dow Jones Islamic5.9% S&P Shariah6.2% MSCI Islamic20.7% MSCI Islamic M-Series6.2% FTSE Shariah14.3% |
| BBIO Bridgebio Pharma Inc | COMPLIANT | 3.18% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| GILD Gilead Sciences Inc | COMPLIANT | 3.13% | AAOIFI14.4% Usmani53.2% Dow Jones Islamic18.6% S&P Shariah21.4% MSCI Islamic53.2% MSCI Islamic M-Series21.4% FTSE Shariah53.2% |
| ABT Abbott Laboratories | COMPLIANT | 3.10% | AAOIFI19.2% Usmani31.9% Dow Jones Islamic17.6% S&P Shariah18.3% MSCI Islamic31.9% MSCI Islamic M-Series18.3% FTSE Shariah30.8% |
| VRTX Vertex Pharmaceuticals Inc | COMPLIANT | 3.02% | AAOIFI1.6% Usmani7.2% Dow Jones Islamic1.7% S&P Shariah1.7% MSCI Islamic7.2% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| DHR Danaher Corp | COMPLIANT | 2.98% | AAOIFI18.2% Usmani28.8% Dow Jones Islamic17.7% S&P Shariah16.7% MSCI Islamic28.8% MSCI Islamic M-Series16.7% FTSE Shariah28.8% |
| AZN AstraZeneca PLC | COMPLIANT | 2.91% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| NVS Novartis AG | COMPLIANT | 2.90% | AAOIFI12.5% Usmani25.9% Dow Jones Islamic11.8% S&P Shariah12.6% MSCI Islamic25.9% MSCI Islamic M-Series12.6% FTSE Shariah25.9% |
| ABBV AbbVie Inc | COMPLIANT | 2.35% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| BMY Bristol-Myers Squibb Co | NON_COMPLIANT | 2.25% | AAOIFI37.3% Usmani51.1% Dow Jones Islamic42.2% S&P Shariah44.8% MSCI Islamic51.1% MSCI Islamic M-Series44.8% FTSE Shariah48.9% |
| Kodiak Sciences Inc | UNSCREENED | 2.23% | no in-house ratios for this holding |
| ISRG Intuitive Surgical Inc | COMPLIANT | 2.17% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| MDT Medtronic PLC | COMPLIANT | 2.12% | AAOIFI24.4% Usmani31.5% Dow Jones Islamic26.4% S&P Shariah27.4% MSCI Islamic31.4% MSCI Islamic M-Series27.4% FTSE Shariah30.2% |
| MCK McKesson Corp | COMPLIANT | 1.88% | AAOIFI12.5% Usmani14.9% Dow Jones Islamic14.5% S&P Shariah15.8% MSCI Islamic14.7% MSCI Islamic M-Series15.8% FTSE Shariah12.5% |
| DXCM Dexcom Inc | COMPLIANT | 1.82% | AAOIFI4.1% Usmani21.7% Dow Jones Islamic4.7% S&P Shariah4.0% MSCI Islamic20.9% MSCI Islamic M-Series4.0% FTSE Shariah19.3% |
| AMGN Amgen Inc | COMPLIANT | 1.47% | AAOIFI24.9% Usmani59.9% Dow Jones Islamic33.6% S&P Shariah35.1% MSCI Islamic59.9% MSCI Islamic M-Series35.1% FTSE Shariah59.9% |
| MDGL Madrigal Pharmaceuticals Inc | COMPLIANT | 1.46% | AAOIFI2.8% Usmani27.9% Dow Jones Islamic3.8% S&P Shariah4.6% MSCI Islamic27.9% MSCI Islamic M-Series4.6% FTSE Shariah27.4% |
| EW Edwards Lifesciences Corp | COMPLIANT | 1.40% | AAOIFI1.4% Usmani5.1% Dow Jones Islamic1.5% S&P Shariah1.5% MSCI Islamic5.1% MSCI Islamic M-Series1.5% FTSE Shariah4.3% |
| REGN Regeneron Pharmaceuticals Inc | COMPLIANT | 1.34% | AAOIFI2.4% Usmani6.5% Dow Jones Islamic3.0% S&P Shariah2.7% MSCI Islamic4.8% MSCI Islamic M-Series2.7% FTSE Shariah4.8% |
| SYK Stryker Corp | COMPLIANT | 1.33% | AAOIFI14.6% Usmani32.2% Dow Jones Islamic11.3% S&P Shariah11.8% MSCI Islamic32.2% MSCI Islamic M-Series11.8% FTSE Shariah31.2% |
| BSX Boston Scientific Corp | COMPLIANT | 1.32% | AAOIFI19.4% Usmani27.9% Dow Jones Islamic10.0% S&P Shariah10.9% MSCI Islamic27.9% MSCI Islamic M-Series10.9% FTSE Shariah27.9% |
| ALNY Alnylam Pharmaceuticals Inc | COMPLIANT | 1.11% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| Teva Pharmaceutical Industries | UNSCREENED | 1.07% | no in-house ratios for this holding |
| CHGCY Chugai Pharmaceutical Co Ltd | COMPLIANT | 1.07% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| Xenon Pharmaceuticals Inc | UNSCREENED | 0.90% | no in-house ratios for this holding |
| ARWR Arrowhead Pharmaceuticals Inc | COMPLIANT | 0.78% | AAOIFI11.9% Usmani46.3% Dow Jones Islamic12.9% S&P Shariah15.5% MSCI Islamic46.3% MSCI Islamic M-Series15.5% FTSE Shariah39.3% |
| Scholar Rock Holding Corp | UNSCREENED | 0.63% | no in-house ratios for this holding |
| STOK Stoke Therapeutics Inc | NON_COMPLIANT | 0.56% | AAOIFI0.1% Usmani0.7% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic0.7% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| MBX Biosciences Inc | UNSCREENED | 0.56% | no in-house ratios for this holding |
| Viking Therapeutics Inc | UNSCREENED | 0.50% | no in-house ratios for this holding |
| PODD Insulet Corp | COMPLIANT | 0.49% | AAOIFI9.6% Usmani30.0% Dow Jones Islamic5.3% S&P Shariah5.9% MSCI Islamic30.0% MSCI Islamic M-Series5.9% FTSE Shariah30.0% |
| GUBRA.CO Gubra A/S | COMPLIANT | 0.47% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| Insmed Inc | UNSCREENED | 0.45% | no in-house ratios for this holding |
| ZEAL.CO Zealand Pharma A/S | NON_COMPLIANT | 0.44% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| KLRA Kailera Therapeutics Inc | NON_COMPLIANT | 0.39% | AAOIFI0.5% Usmani0.8% Dow Jones Islamic— S&P Shariah— MSCI Islamic0.8% MSCI Islamic M-Series— FTSE Shariah0.0% |
| First American Treasury Obliga | UNSCREENED | 0.35% | no in-house ratios for this holding |
| NTLA Intellia Therapeutics Inc | NON_COMPLIANT | 0.31% | AAOIFI4.1% Usmani8.6% Dow Jones Islamic5.1% S&P Shariah4.1% MSCI Islamic8.6% MSCI Islamic M-Series4.1% FTSE Shariah0.0% |
| IONS Ionis Pharmaceuticals Inc | NON_COMPLIANT | 0.26% | AAOIFI21.0% Usmani67.5% Dow Jones Islamic23.0% S&P Shariah25.1% MSCI Islamic67.5% MSCI Islamic M-Series25.1% FTSE Shariah58.8% |
The published standards disagree about this fund by 39 points of portfolio weight — 69.5% of it passes AAOIFI, 30.5% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 69.5% ratios fail on 9.9% 20.6% not rated under AAOIFI
ratios pass on 36.7% ratios fail on 42.6% 20.6% not rated under Usmani
ratios pass on 63.2% ratios fail on 12.8% 23.9% not rated under Dow Jones Islamic
ratios pass on 65.6% ratios fail on 10.5% 23.9% not rated under S&P Shariah
ratios pass on 30.5% ratios fail on 48.9% 20.5% not rated under MSCI Islamic
ratios pass on 65.1% ratios fail on 10.9% 23.9% not rated under MSCI Islamic M-Series
ratios pass on 37.6% ratios fail on 38.9% 23.5% not rated under FTSE Shariah
37 of 46 listed holdings carry our own per-methodology verdicts (90% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 28 (69% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
Methodology breakdown computing — it will appear here on its own.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Why this signal?
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
Tema Heart & Health ETF (HRTS) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
🕌 In-house Compliance Research
Computing the full ratio and business-activity breakdown for HRTS — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 60.50 | NEUTRAL |
| Stochastic %K (14) | 72.44 | NEUTRAL |
| CCI (20) | 76.62 | NEUTRAL |
| Williams %R (14) | -27.56 | NEUTRAL |
| MACD (12,26,9) | 0.04 | BUY |
| ROC (10) | 0.95 | BUY |
| Momentum (10) | 0.37 | BUY |
| EMA (10) | 38.97 | BUY |
| SMA (10) | 39.08 | BUY |
| EMA (20) | 38.46 | BUY |
| SMA (20) | 38.42 | BUY |
| EMA (30) | 38.09 | BUY |
| SMA (30) | 37.68 | BUY |
| EMA (50) | 37.64 | BUY |
| SMA (50) | 37.15 | BUY |
| EMA (100) | 36.98 | BUY |
| SMA (100) | 37.12 | BUY |
| EMA (200) | 36.05 | BUY |
| SMA (200) | 35.70 | BUY |
About Tema Heart & Health ETF
Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from products or services related to GLP-1 and the treatment of cardiovascular diseases and/or metabolic diseases, as defined by the Centers for Diseases Control and Preventions. The fund generally is expected to consist of more than 15 companies but not more than 100 companies. The fund is non-diversified.
Background via Yahoo Finance — informational, not part of the verdict.
Weak — low conviction, small size or skip
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BULLISH | 44 |
| ⏱ 15-Min | BULLISH | 23 |
| ⏲ 5-Min | BEARISH | 71 |
Momentum & Volume
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is a fund screened on its name?
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
What does unrated weight mean?
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
Does the issuer's board make it compliant?
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
How often is this re-screened?
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider Activity (90d)
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
NO DATA 0 buys · 0 sells
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-11-03 · Asset managers net 928584 (+5135)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.